Thrombocytopenia with gabapentin usage
Dilek Ataklı, Burcu Yüksel, Pelin Doğan Ak, Hande Sarıahmetoğlu, Hüseyin Sarı
Abstract
Dilek Ataklı, Burcu Yüksel, Pelin Doğan Ak, Hande Sarıahmetoğlu, Hüseyin Sarı
Abstract
Gabapentin is an antiepileptic drug approved for adjunctive therapy for partial seizures. We report a case of a patient who had thrombocytopenia with the dose of 2400 mg/day of gabapentin. The causal relationship between gabapentin and thrombocytopenia was revealed by dramatic increase in thrombocyte count following the cessation of the gabapentin treatment. To our knowledge, this is the first case report with a hematopoietic side effect of gabapentin.
OpenAlex reports 6 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Gabapentin is an antiepileptic drug approved for adjunctive therapy for partial seizures. We report a case of a patient who had thrombocytopenia with the dose of 2400 mg/day of gabapentin. The causal relationship between gabapentin and thrombocytopenia was revealed by dramatic increase in thrombocyte count following the cessation of the gabapentin treatment. To our knowledge, this is the first case report with a hematopoietic side effect of gabapentin.
Key concepts: Gabapentin, Medicine, Anesthesia, Drug, Epilepsy, Antiepileptic drug, Platelet, Pharmacology